These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 20166295)

  • 1. Vaccines: for whose benefit?
    Paul Y
    Indian J Med Ethics; 2010; 7(1):30-1. PubMed ID: 20166295
    [No Abstract]   [Full Text] [Related]  

  • 2. Financial incentives and the prescription of newer vaccines by doctors in India.
    Lodha R; Bhargava A
    Indian J Med Ethics; 2010; 7(1):28-30. PubMed ID: 20166294
    [No Abstract]   [Full Text] [Related]  

  • 3. The medical trade.
    Bawaskar HS
    Indian J Med Ethics; 2013; 10(4):278. PubMed ID: 24152357
    [No Abstract]   [Full Text] [Related]  

  • 4. No more free drug samples?
    Chimonas S; Kassirer JP
    PLoS Med; 2009 May; 6(5):e1000074. PubMed ID: 19434227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical registries: Should physicians accept payments for enrolling patients?
    Jariwala N; Lipoff JB
    J Am Acad Dermatol; 2017 Jul; 77(1):183-185. PubMed ID: 28619564
    [No Abstract]   [Full Text] [Related]  

  • 6. The General Medical Council and doctors' financial interests.
    Adlington K; Abbasi K; Godlee F
    BMJ; 2015 Jan; 350():h474. PubMed ID: 25630755
    [No Abstract]   [Full Text] [Related]  

  • 7. Physicians' responsibility to understand patients' pain.
    Learch R; Cumberledge J
    Virtual Mentor; 2013 May; 15(5):430-3. PubMed ID: 23680564
    [No Abstract]   [Full Text] [Related]  

  • 8. Are free drug samples in the best interest of our patients?
    Quigley TF
    JAAPA; 2010 Nov; 23(11):15. PubMed ID: 21086882
    [No Abstract]   [Full Text] [Related]  

  • 9. [Editorial: Hebebrand, J., Blanz, B., Herpertz-Dahlmann, B. & Lehmkuhl, G. 2012. Increase in the abundance of medical treatments, ethical principles and conflicts of interest in cooperation with the pharmaceutical industry].
    Frank R
    Z Kinder Jugendpsychiatr Psychother; 2013 Mar; 41(2):145-9. PubMed ID: 23425616
    [No Abstract]   [Full Text] [Related]  

  • 10. Psychiatrists' relationships with pharmaceutical companies: part of the problem or part of the solution?
    Insel TR
    JAMA; 2010 Mar; 303(12):1192-3. PubMed ID: 20332407
    [No Abstract]   [Full Text] [Related]  

  • 11. Association of Pharmaceutical Industry Marketing of Opioid Products to Physicians With Subsequent Opioid Prescribing.
    Hadland SE; Cerdá M; Li Y; Krieger MS; Marshall BDL
    JAMA Intern Med; 2018 Jun; 178(6):861-863. PubMed ID: 29799955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doping Doctors: The Influence of the Marketing Departments of Pharmaceutical Companies on Physician and Researcher Behavior in Japan.
    Ichikawa I; Clayton EW
    Account Res; 2016; 23(4):245-53. PubMed ID: 26829657
    [No Abstract]   [Full Text] [Related]  

  • 13. Marketing pharmaceuticals: a constitutional right to sell prescriber-identified data?
    Gostin LO
    JAMA; 2012 Feb; 307(8):787-8. PubMed ID: 22357827
    [No Abstract]   [Full Text] [Related]  

  • 14. Physician assistants for sale: will prescribe for food.
    Anderson J
    JAAPA; 2011 Aug; 24(8):57-8. PubMed ID: 21850922
    [No Abstract]   [Full Text] [Related]  

  • 15. An insider's perspective: defense of the pharmaceutical industry's marketing practices.
    Johar K
    Albany Law Rev; 2012-2013; 76(1):299-334. PubMed ID: 23577377
    [No Abstract]   [Full Text] [Related]  

  • 16. Physician Exposure to Direct-to-Consumer Pharmaceutical Marketing: Potential for Creating Prescribing Bias.
    Brown JL
    Am J Med; 2017 Jun; 130(6):e247-e248. PubMed ID: 28089801
    [No Abstract]   [Full Text] [Related]  

  • 17. [A plebiscite for medicine? Vaccines and democracy].
    Moulin AM
    Med Sci (Paris); 2016 May; 32(5):431-2. PubMed ID: 27225907
    [No Abstract]   [Full Text] [Related]  

  • 18. Balancing patient care with profitability: Ethical considerations.
    Jayakumar KL; Lipoff JB
    J Am Acad Dermatol; 2017 Aug; 77(2):382-384. PubMed ID: 28711093
    [No Abstract]   [Full Text] [Related]  

  • 19. Clarifying the costs of conflicts of interest.
    Mayes C; Lipworth W; Kerridge I
    Int J Clin Pract; 2015 Mar; 69(3):384-5. PubMed ID: 25727803
    [No Abstract]   [Full Text] [Related]  

  • 20. Ethics Roundtable: "Cost and the Non-Adherent Patient".
    Baumrucker SJ; Macmillan PJ; Stolick M; Adkins RW; Carter GT; York P
    Am J Hosp Palliat Care; 2018 Mar; 35(3):555-559. PubMed ID: 28285541
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.